Pure Global
ec14bb23f67ad7760fb0866a4038a371

ANTI - A,B (ABO3)

DIAGAST·IV·Ecuador ARCSA·Registered December 07, 2022
Device classification
Risk class
IV
Product type
In Vitro Diagnostic
Brand name
DIAGAST
Commercial name
19-294 IVD Reagents/Kits, Immunohematology, Blood Pooling
Registration information
Analysis ID
ec14bb23f67ad7760fb0866a4038a371
Registration date
December 07, 2022
Expiration date
December 07, 2027
Manufacturer
Name
DIAGAST
City
LOOS
Country
FRENCH
Address
251 AVENUE EUGENE AVINNEE, 59120 LOOS- FRANCE
Product owner
Name
DIAGAST
Country
FRENCH
Authorized representative
Name
SUMINISTROS MEDICOS MANOSALVAS VILLAGOMEZ MV ASOCIADOS CIA. LTDA.
Address
BARRIO JIPIJAPA STREET: ISLA FERNANDINA NO. N42-40 INTERSECCION ISLA TORTUGA
Phone
2252800
Product use

THEY ARE USED TO PERFORM THE GLOBULAR TEST FOR THE DETERMINATION OF ABO BLOOD GROUP. THEY ALLOW TO DETERMINE THE PRESENCE OF ERYTHROCYTE ANTIGENS A AND / OR B ON THE SURFACE OF HUMAN HEMATIES.

About this record

Access comprehensive regulatory information for ANTI - A,B (ABO3) in the Ecuador medical device market through Pure Global AI's free database. This IV medical device is registered under ARCSA ID ec14bb23f67ad7760fb0866a4038a371 and manufactured by DIAGAST. The device was registered on December 07, 2022.

This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.